Micotef

Miconazole nitrate, the active ingredient in Micotef, is an imidazole antifungal presented as a vaginal formulation for local use. It treats vulvovaginal candidiasis, a common yeast infection, in adult women by targeting the fungal cells that cause the condition and relieve associated symptoms such as itching and discharge.

GNH USA supplies Micotef as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide with a focus on quality assurance and regulatory compliance across EU and global markets and timely delivery.

Micotef, an imidazole antifungal, acts on Candida species that cause vaginal yeast infections.

Vulvovaginal candidiasis: reduces fungal load and relieves symptoms such as itching, burning, and abnormal discharge. Recurrent vulvovaginal candidiasis: helps prevent repeat episodes when used as directed by a healthcare professional. Vaginal yeast infection: eradicates Candida overgrowth to restore normal vaginal flora.

Miconazole nitrate may cause local or systemic adverse reactions, most of which are mild and transient.

Common Side Effects: - Local irritation: mild burning or stinging at the application site. - Vaginal discharge: increased or altered discharge during treatment. - Itching: transient pruritus of the vulvar area. - Unpleasant odor: temporary change in vaginal odor.

Serious or Rare Side Effects: - Allergic reaction: rash, swelling, or hives indicating hypersensitivity. - Severe skin reaction: Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Liver enzyme elevation: signs of hepatic dysfunction such as jaundice. - Vaginal ulceration: painful sores requiring medical evaluation.

Before using Micotef, consider the following safety measures and warnings.

Pregnancy: consult a healthcare professional before use, as safety data are limited. Breastfeeding: use with caution; discuss potential risks with a physician. Allergy: avoid if known hypersensitivity to miconazole or other imidazoles. Hepatic impairment: use only under medical supervision in patients with severe liver disease. Prolonged use: do not exceed recommended duration without physician guidance. Store at ambient temperature: keep in original packaging, protect from moisture and direct sunlight.

Miconazole nitrate can affect the activity of other medicines; interactions are classified by their clinical significance.

Major Interactions (Avoid): - Systemic azole antifungals (e.g., ketoconazole, fluconazole): increased risk of toxicity due to additive inhibition of CYP450 enzymes. - Warfarin: enhanced anticoagulant effect, may require monitoring of INR. - Oral contraceptives: reduced efficacy, consider alternative non‑hormonal contraception. - Rifampin: strong CYP450 inducer that may lower miconazole levels, decreasing effectiveness.

Moderate Interactions (Monitor Closely): - Topical corticosteroids: may increase local irritation when used together. - Antihistamines: possible additive effect on sedation if systemic absorption occurs. - Other vaginal products (e.g., douches, spermicides): may interfere with drug absorption.